Literature DB >> 21128999

Phenotypic diversity of peripheral blood plasma cells in primary Sjögren's syndrome.

E A Szyszko1, J G Brun, K Skarstein, A B Peck, R Jonsson, K A Brokstad.   

Abstract

Production of autoantibodies is one of the main features of primary Sjögren's syndrome (pSS). Long-lived plasma cells (PC) can produce autoantibodies for prolonged period of times without being affected by immunosuppressive therapies. As of today, little is known about the long-lived PC subset and their contribution to autoimmunity. We have characterized the phenotypic and migratory properties of peripheral blood PC isolated from pSS patients (grouped by focus score, FS) and compared them to PC from rheumatoid arthritis (RA) patients and normal non-autoimmune subjects. We observed two populations of PC in all study groups, CD19+ PC and CD19- PC. Interestingly, the CD19- PC subset was most prominent in autoimmune patients (pSS and RA) compared to normal controls. Further investigation of the PC phenotype revealed that a high percentage of both CD19+ and CD19- PC isolated from pSS and RA patients did not express the CD27 marker, which is normally highly expressed on all types of PC. Differences in the expression of markers such as IgM, IgG, CD95 and CXCR3 in the group with high FS compared to FS = 1, underscore the heterogeneity of pSS patient group and demonstrate that phenotypic pattern of circulating PC associates with the severity of inflammation in the salivary glands of these patients. Our migration experiments show that addition of CXCL12 to PC in vitro, do not alter the migration potential of PC in any group tested. However, we observed an overall higher spontaneous migration of PC from pSS compared to both RA and normal controls.
© 2011 The Authors. Scandinavian Journal of Immunology © 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21128999     DOI: 10.1111/j.1365-3083.2010.02475.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  12 in total

1.  A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus.

Authors:  K Szabó; G Papp; A Szántó; T Tarr; M Zeher
Journal:  Clin Exp Immunol       Date:  2015-10-21       Impact factor: 4.330

2.  Differential transcriptome and development of human peripheral plasma cell subsets.

Authors:  Swetha Garimalla; Doan C Nguyen; Jessica L Halliley; Christopher Tipton; Alexander F Rosenberg; Christopher F Fucile; Celia L Saney; Shuya Kyu; Denise Kaminski; Yu Qian; Richard H Scheuermann; Greg Gibson; Iñaki Sanz; F Eun-Hyung Lee
Journal:  JCI Insight       Date:  2019-05-02

3.  Vaccine-induced plasmablast responses in rhesus macaques: phenotypic characterization and a source for generating antigen-specific monoclonal antibodies.

Authors:  Eduardo L V Silveira; Sudhir P Kasturi; Yevgeniy Kovalenkov; Ata Ur Rasheed; Patryce Yeiser; Zarpheen S Jinnah; Traci H Legere; Bali Pulendran; Francois Villinger; Jens Wrammert
Journal:  J Immunol Methods       Date:  2014-11-08       Impact factor: 2.303

4.  Analysis of IgM antibody production and repertoire in a mouse model of Sjögren's syndrome.

Authors:  Jill M Kramer; Nichol E Holodick; Teresa C Vizconde; Indu Raman; Mei Yan; Quan-Zhen Li; Daniel P Gaile; Thomas L Rothstein
Journal:  J Leukoc Biol       Date:  2015-09-17       Impact factor: 4.962

5.  Ro52- and Ro60-specific B cell pattern in the salivary glands of patients with primary Sjögren's syndrome.

Authors:  L A Aqrawi; K Skarstein; G Øijordsbakken; K A Brokstad
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

6.  Expression of IL-17, IL-23 and their receptors in minor salivary glands of patients with primary Sjögren's syndrome.

Authors:  Diana Mieliauskaite; Irena Dumalakiene; Rita Rugiene; Zygmunt Mackiewicz
Journal:  Clin Dev Immunol       Date:  2012-01-03

7.  Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome.

Authors:  Saba Nayar; Joana Campos; Charlotte G Smith; Valentina Iannizzotto; David H Gardner; Serena Colafrancesco; Elena Pipi; Florian Kollert; Kelly J Hunter; Charlotte Brewer; Christopher Dominic Buckley; Simon J Bowman; Roberta Priori; Guido Valesini; Maria Juarez; William A Fahy; Benjamin A Fisher; Andrew Payne; Rodger A Allen; Francesca Barone
Journal:  Ann Rheum Dis       Date:  2018-11-24       Impact factor: 19.103

Review 8.  B cell dysregulation in primary Sjögren's syndrome: A review.

Authors:  Hazim Mahmoud Ibrahem
Journal:  Jpn Dent Sci Rev       Date:  2019-10-21

9.  The protein tyrosine phosphatase PTP1B is a negative regulator of CD40 and BAFF-R signaling and controls B cell autoimmunity.

Authors:  David Medgyesi; Elias Hobeika; Robert Biesen; Florian Kollert; Adriano Taddeo; Reinhard E Voll; Falk Hiepe; Michael Reth
Journal:  J Exp Med       Date:  2014-03-03       Impact factor: 14.307

10.  Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies.

Authors:  Olga Kryštůfková; Sevim Barbasso Helmers; Paulius Venalis; Vivianne Malmström; Eva Lindroos; Jiří Vencovský; Ingrid E Lundberg
Journal:  Arthritis Res Ther       Date:  2014-10-10       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.